"When I was starting to use Dupilumab in my patients, I thought they were getting more positive results than what I would have expected. When I was seeing patients three or four months after being on treatment they were ecstatic, the were like 'Wow, this is really life changing.'"Dr Jensen Yeung returns to the JCMS Author Interviews podcast to talk to Kirk Barber about his article, "Short-Term Evaluation of the Real-World Efficacy and Safety of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis" which is featured in the Sept/Oct Edition of the Journal of Cutaneous Medicine and Surgery.Dr. Jensen Yeung is a certified dermatologist and medical director of the Phototherapy Education and Research Centre of Women's College Hospital, an Assistant Professor at the University of Toronto, and an Associate Editor of JCMS.Our theme music is composed by Lee RosevereAnd our producer is David McGuffin of Explore Podcast Productions in Ottawa.